author-photo

James E. Thompson

University of Pennsylvania

25

Papers

683

Citations

Citation Trend

Filter By

Papers (22) Sort By

Journal Conference Others

Intensive chemotherapy vs. hypomethylating agents in older adults with newly diagnosed high-risk acute myeloid leukemia: A single center experience

2018 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (7)
Evaluation of the effect of cellular SMS reminders on consistency of antiretroviral therapy pharmacy pickups in HIV-infected adults in Botswana: a randomized controlled trial

2017 Health Psychology and Behavioral Medicine
Show All
- Source
- Cite
- Save
Citations (9)
Predicting outcome based on minimal residual disease (MRD) using multiparameter flow cytometry (FC) in acute myeloid leukemia (AML) patients (Pts).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Myelodysplastic syndrome (MDS) and autoimmune diseases (AD): Hypomethylating agents to treat both.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Mitochondrial DNA mutations provide selective advantage in hematopoietic stem cell niche

2011 Mitochondrion
Show All
- Source
- Cite
- Save
Citations (0)
Diagnostic microRNAs in myelodysplastic syndrome

2011 Experimental Hematology
Show All
- Source
- Cite
- Save
Citations (52)
Interferon regulatory factor-8-driven myeloid differentiation is regulated by 12/15-lipoxygenase-mediated redox signaling

2010 Experimental Hematology
Show All
- Source
- Cite
- Save
Citations (9)
cells mTOR regulates cell survival after etoposide treatment in primary AML

2010
Show All
- Source
- Cite
- Save
Citations (0)
A Phase I Study of Bexarotene, a Retinoic X Receptor Agonist, in Non-M3 Acute Myeloid Leukemia

2008 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (26)
A Phase I Study of Bexarotene, a Retinoic X Receptor Agonist, in Non-M3 Acute Myeloid Leukemia. Commentary

2008 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)